Effects of PCSK9 Inhibitors on Early Neurologic Deterioration in Patients with Acute Non-Cardioembolism without Hemorrhagic Transformation After Intravenous Thrombolysis.

Junjie LeiQian FanXiaofeng ChenWenbin LiYanfang PengYiming CaiXudong LiuChenhao LiuLei Zhang

Published in: Current neurovascular research (2024)

The use of PCSK9 inhibitors can reduce the incidence of early neurological deterioration in patients with acute non-cardioembolism and non-hemorrhagic transformation after intravenous thrombolysis.

Keyphrases

pulmonary embolism
acute ischemic stroke
high dose
risk factors